Safety and efficacy of infliximab in a patient with active WHO class IV lupus nephritis

By Hayat Sawsan   Uppal Sukhbir   Narayanan Nampoory M.   Johny Kaivilayil   Gupta Ramkumar   Al-Oun Mohammed  

Clinical Rheumatology, Vol. 26, Iss. 6, 2007-06 ,pp. : 973-975

Springer Publishing Company

Access to resources Recommend Favorite

Study of the efficacy of mizoribine in lupus nephritis in Chinese patients

By Zhang Miao   Xing Chang   Liu Jia  

Rheumatology International, Vol. 33, Iss. 11, 2013-11 ,pp. : 2737-2742

Springer Publishing Company

Access to resources Recommend Favorite

Mizoribine therapy for patients with lupus nephritis: the association between peak mizoribine concentration and clinical efficacy

By Kuroda Takeshi   Hirose Shintaro   Tanabe Naohito   Sato Hiroe   Nakatsue Takeshi   Ajiro Jyunya   Wada Yoko   Murakami Syuichi   Hasegawa Hisashi   Ito Satoshi   Sakatsume Minoru   Nakano Masaaki   Gejyo Fumitake  

Modern Rheumatology, Vol. 17, Iss. 3, 2007-06 ,pp. : 206-212

Springer Publishing Company

Access to resources Recommend Favorite

The efficacy of low-dose mycophenolate mofetil for treatment of lupus nephritis in Taiwanese patients with systemic lupus erythematosus

By Weng Meng-Yu   Weng Chia-Tse   Liu Ming-Fei  

Clinical Rheumatology, Vol. 29, Iss. 7, 2010-07 ,pp. : 771-775

Springer Publishing Company

Access to resources Recommend Favorite

Therapeutic efficacy and safety profile of infliximab in active systemic lupus erythematosus

By Hayat Sawsan Johar   Uppal Sukhbir Singh  

Modern Rheumatology, Vol. 17, Iss. 2, 2007-04 ,pp. : 174-177

Springer Publishing Company

Access to resources Recommend Favorite